Loading...
Please wait, while we are loading the content...
Similar Documents
Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes
| Content Provider | Scilit |
|---|---|
| Author | Aprile, Ja Russo, M. Pepe, Ms Loughran, Tp Jr |
| Copyright Year | 1991 |
| Description | The activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes (LGL) were studied in vitro. Anti-CD3 monoclonal antibody (MoAb) alone (P less than .01) and recombinant interleukin-2 (IL-2) alone (P less than .01) caused significant stimulation of peripheral blood mononuclear cells (PBMC) from four CD3+ LGL leukemia patients, as measured in a 3H-thymidine incorporation assay. Recombinant interleukin-4 (IL-4) alone had no effect (P = .11). The combination signals of anti-CD3 MoAb and either IL-2 or IL-4 produced a proliferative response greater than anti-CD3 MoAb alone (P less than .01) or lymphokine alone (P less than .01). Leukemic LGL, purified by two-color sorting, were subsequently activated by anti-CD3 MoAb and IL-2 and assessed for DNA content by viable Hoechst No. 33342 (HO) staining. Results of these studies demonstrated that leukemic LGL were stimulated directly by anti-CD3 MoAb and IL-2, with the percentage of cells in cell cycle (S + G2/M) ranging from 16% to 72%. Normal CD3+ LGL were also stimulated to enter the cell cycle by anti-CD3 and IL-2. These results show that leukemic LGL proliferate in vitro after activation through the T-cell receptor and/or lymphokine. |
| Related Links | https://ashpublications.org/blood/article-pdf/78/5/1282/606364/1282.pdf |
| Ending Page | 1285 |
| Page Count | 4 |
| Starting Page | 1282 |
| DOI | 10.1182/blood.v78.5.1282.1282 |
| Journal | Blood |
| Issue Number | 5 |
| Volume Number | 78 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 1991-09-01 |
| Access Restriction | Open |
| Subject Keyword | Hematology Research and Experimental Medicine Antibody Lymphocytes Signals Lgl Recombinant Granular Viable Anti Cd3 Leukemic Journal: Blood (Vol- 82, Issue- 5) |
| Content Type | Text |
| Resource Type | Article |